Solid Biosciences $240 million private placement
We advised the lead placement agents
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Korro Bio $85 million private placement
We advised the placement agents
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
Revolution Medicines $1 billion at-the-market offering
We advised the sales agent on the offering
RXO $400 million senior notes offering
We advised the representative of the initial purchasers on the offering
Averin Capital Acquisition $250 million IPO
We advised the underwriters on the IPO
AgomAb Therapeutics $200 million IPO
We advised the representatives of the several underwriters on the IPO
Perspective Therapeutics $175 million equity offering
We advised the representatives of the underwriters on the transaction
Vistra $2.25 billion secured notes offering
We advised the underwriters on the offering
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026